Squarepoint
DGX icon

Squarepoint’s Quest Diagnostics DGX Stock Holding History

Squarepoint’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.8M Sell
345,788
-220,012
-39% -$42.7M 0.08% 247
2025
Q4 		$98.2M Sell
565,800
-71,492
-11% -$13M 0.1% 210
2025
Q3 		$121M Sell
637,292
-205,999
-24% -$36.6M 0.12% 169
2025
Q2 		$151M Buy
843,291
+688,297
+444% +$120M 0.16% 121
2025
Q1 		$26.2M Buy
154,994
+151,854
+4,836% +$24.9M 0.03% 572
2024
Q4 		$474K Buy
3,140
+143
+5% +$22.2K ﹤0.01% 3770
2024
Q3 		$465K Sell
2,997
-58,805
-95% -$8.78M ﹤0.01% 3148
2024
Q2 		$8.46M Sell
61,802
-42,016
-40% -$5.75M 0.01% 1032
2024
Q1 		$13.8M Buy
103,818
+22,851
+28% +$2.96M 0.02% 810
2023
Q4 		$11.2M Sell
80,967
-79,023
-49% -$10.4M 0.02% 875
2023
Q3 		$19.5M Sell
159,990
-24,556
-13% -$3.27M 0.05% 461
2023
Q2 		$25.9M Buy
184,546
+145,514
+373% +$20.1M 0.08% 287
2023
Q1 		$5.52M Buy
39,032
+19,639
+101% +$2.81M 0.02% 827
2022
Q4 		$3.03M Sell
19,393
-6,737
-26% -$968K 0.01% 1118
2022
Q3 		$3.21M Sell
26,130
-29,784
-53% -$3.92M 0.02% 1009
2022
Q2 		$7.43M Sell
55,914
-79,225
-59% -$10.8M 0.04% 513
2022
Q1 		$18.5M Buy
135,139
+126,470
+1,459% +$17.6M 0.08% 262
2021
Q4 		$1.5M Sell
8,669
-88,340
-91% -$13.4M ﹤0.01% 1433
2021
Q3 		$14.1M Buy
97,009
+41,453
+75% +$6.07M 0.04% 393
2021
Q2 		$7.33M Sell
55,556
-67,441
-55% -$8.83M 0.03% 578
2021
Q1 		$15.8M Buy
122,997
+11,500
+10% +$1.42M 0.09% 226
2020
Q4 		$13.3M Buy
+111,497
New +$13.6M 0.1% 194
2020
Q3 		– Sell
-11,855
Closed -$1.35M – 2547
2020
Q2 		$1.35M Sell
11,855
-39,139
-77% -$4.15M 0.02% 790
2020
Q1 		$4.09M Sell
50,994
-49,723
-49% -$5.15M 0.1% 241
2019
Q4 		$10.8M Sell
100,717
-132,824
-57% -$13.9M 0.06% 275
2019
Q3 		$25M Buy
233,541
+201,868
+637% +$20.7M 0.22% 107
2019
Q2 		$3.23M Buy
+31,673
New +$3.04M 0.03% 591
2019
Q1 		– Sell
-11,410
Closed -$950K – 2198
2018
Q4 		$950K Sell
11,410
-162,548
-93% -$15.2M 0.01% 941
2018
Q3 		$18.8M Buy
173,958
+170,200
+4,529% +$18.7M 0.22% 110
2018
Q2 		$413K Sell
3,758
-175,133
-98% -$18.2M 0.01% 1257
2018
Q1 		$17.9M Buy
178,891
+74,448
+71% +$7.62M 0.28% 86
2017
Q4 		$10.3M Sell
104,443
-149,637
-59% -$14.2M 0.18% 119
2017
Q3 		$23.8M Buy
254,080
+164,498
+184% +$17.5M 0.46% 35
2017
Q2 		$9.96M Buy
+89,582
New +$9.47M 0.2% 115
2016
Q4 		– Sell
-34,846
Closed -$2.95M – 1797
2016
Q3 		$2.95M Buy
+34,846
New +$2.93M 0.2% 130
2016
Q2 		– Sell
-23,671
Closed -$1.69M – 1153
2016
Q1 		$1.69M Buy
+23,671
New +$1.59M 0.13% 217
2015
Q3 		– Sell
-2,818
Closed -$204K – 451
2015
Q2 		$204K Buy
+2,818
New +$208K 0.07% 371

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Squarepoint's DGX Position: Q1 2026 in Review

Squarepoint reduced its Quest Diagnostics (DGX) stake by 39% in Q1 2026, selling an estimated $42.7M and leaving 345,788 shares worth $67.8M. The position accounts for 0.08% of the portfolio, ranked #247.

Squarepoint first reported a position in DGX in Q2 2015 and has held it in 37 quarters since. The position peaked at $151M in Q2 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Squarepoint held 345,788 shares of Quest Diagnostics worth $67.8M as of Q1 2026.
  • Squarepoint sold 220,012 Quest Diagnostics shares in Q1 2026, an estimated $42.7M.
  • Quest Diagnostics made up 0.08% of Squarepoint's portfolio in Q1 2026, its #247 holding.
  • Squarepoint first reported a position in Quest Diagnostics in Q2 2015 and has held it in 37 quarters since.
  • Squarepoint's Quest Diagnostics position peaked at $151M in Q2 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.